← Back to headlines
UroGen Settles Patent Dispute with Teva Over Jelmyto
UroGen Pharma has reached a settlement with Teva Pharmaceuticals regarding a patent dispute concerning its drug Jelmyto.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Volkswagen Approves Major Restructuring Plan Targeting 100,000 Jobs
27m ago
Trump Administration Seeks Supreme Court Approval for Mail Ballot Restrictions
50m ago
New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism
51m ago
Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal
55m ago